Skip to main content

PLERIXAFOR

Generic: plerixafor

Verified·Apr 23, 2026
Manufacturer
Sanofi
NDC
70771-1776
ICD-10 indication
C90.00

Affordability Check

How much will you actually pay for PLERIXAFOR?

In 30 seconds, see every legitimate way to afford PLERIXAFOR — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About PLERIXAFOR

What is this medication? Plerixafor is a prescription medication used to move blood-forming stem cells from the bone marrow into the peripheral bloodstream. This process is known as stem cell mobilization. It is specifically indicated for adult patients with certain types of cancers, such as non-Hodgkin lymphoma and multiple myeloma, who are preparing to undergo an autologous stem cell transplant. By increasing the number of stem cells available in the blood, the medication makes it easier for healthcare providers to collect enough cells for the procedure.

The medication is typically administered as an injection under the skin after the patient has received several days of treatment with another drug called granulocyte colony-stimulating factor. This combination approach helps ensure that a sufficient quantity of stem cells can be harvested using a process called apheresis. Once the cells are collected and processed, they are later returned to the patient's body to help rebuild healthy bone marrow and blood cell levels following high-dose chemotherapy treatments.

Copay & patient assistance

  • Patient Copay Amount: Not Publicly Available
  • Maximum Annual Benefit Limit: Not Publicly Available
  • Core Eligibility Restrictions: U.S. Residents Only
  • RxBIN, PCN, and Group numbers: Not Publicly Available

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.

Rare-disease navigation (specialists, trials, patient communities)

PLERIXAFOR treats 4 rare conditions. For in-depth disease pages on our sister site:

UniteRare.org is our sister site for rare-disease navigation — same editorial team, same accuracy standards.